Efficacy of platinum in advanced triple-negative breast cancer with germline BRCA mutation determined by next generation sequencing.
Compare Appoptosis lab reagents for research
Suppliers for Lab polyclonals Our used antibodies in Pubmed.
Compare ELISA lab reagents for research
Suppliers for Lab ELISAs Our used References in Pubmed.
Compare ELISA lab reagents for research
Suppliers for Lab reagents Our used recombinants in Pubmed.
Compare Pcr lab reagents for research
Suppliers for Lab Assays Our used References in Pubmed.
polyclonal Lab Reagents for Research
Promoted Lab polyclonals Our used rec. in Pubmed.
Recombinant Core Streptavidin (r-cSA)
Product Name: Recombinant Core Streptavidin (rc-SA) Catalog Number: NRPA09S Packaging Details: 1mg, 10mg, 100mg, 500mg Formulation: lyophilized from 5 mM PB (4 mM Na2HPO4, 1 mM NaH2PO4, pH 7.4) Mol. Weight: 13.5 kDa subunit; Tetramer 54kDa Pi theory: 6.04 Theoretical activity: 18.1 U / mg protein (rc-SA: Biotin = 1: 4 (mol: mol)) Resources: Escherichia … Read more
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
The Nationwide Institute of Allergy and Infectious Ailments (NIAID) Virology High quality Assurance (VQA) established a sturdy proficiency testing program for Sanger sequencing (SS)-based HIV-1 drug resistance (HIVDR) testing in 2001. Whereas most of the classes discovered through the growth of such applications may additionally apply to subsequent technology sequencing (NGS)-based HIVDR assays, challenges stay … Read more
Prediction for Intravenous Immunoglobulin Resistance Combining Genetic Risk Loci Identified From Next Generation Sequencing and Laboratory Data in Kawasaki Disease
Background: Kawasaki illness (KD) is the most typical reason for acquired coronary heart illness. A proportion of sufferers have been immune to intravenous immunoglobulin (IVIG), the first therapy of KD, and the mechanism of IVIG resistance stays unclear. The accuracy of present fashions predictive of IVIG resistance is inadequate and does not meet the scientific expectations. … Read more
Next Generation Sequencing Reveals a Synchronous Trilateral Lung Adenocarcinoma Case with Distinct Driver Alterations of EGFR 19 Deletion or EGFR 20 Insertion or EZR-ROS1 Fusion
Goal: Synchronous a number of main lung most cancers (SMPLC) has a reported incidence from 0.5% to 2% in lung most cancers, and the surgical remedy and prognosis had been fairly numerous. With the invention of driver mutations in lung adenocarcinoma (ADC), next-generation sequencing (NGS) would offer an specific reply to the important thing query, whether … Read more